Cardiac Arrhythmia Network of Canada (CANet)
| Website: | https://www.canet-nce.ca |
| LinkedIn: | |
| Twitter: |
About Us
The Cardiac Arrhythmia Network of Canada is a national research network established in December, 2014 through the Networks of Centres of Excellence (NCE) to address this national health problem.
The Cardiac Arrhythmia Network of Canada (CANet) brings together health care professionals, academia, government, industry, not-for-profit, and patients to support new ideas and ground-breaking research. Ultimately, CANet will provide innovative therapies and solutions to reduce premature deaths and suffering caused by heart rhythm disturbances.
Although heart rhythm care is a young clinical specialty, it has important roots in Canada. The first external cardiac pacemaker was developed in Toronto, and the first implantable heart recorder in London, Ontario. The Canadian heart rhythm research community, building on its past successes, is a world leader in this field.
CANet is committed to developing effective practical solutions that address unmet needs, and promote their use in personal, healthcare, and business applications. Our approach is to put the right tools in the right hands at the right time, to empower:
- Patients to manage their own health
- Caregivers to improve patient care at the bedside and in the community
- Healthcare providers to give timely, effective, and efficient services
Patient engagement, knowledge translation, and commercialization of new therapies are central to CANet’s mission. A unique Patient Advisory Committee will consult and make recommendations about CANet’s governance, operations, and research programs.
CANet’s multidisciplinary and cross-sectoral approach is designed to foster innovation and excellence. This will enable CANet to come up with fresh ideas, set clear research priorities, build efficient and patient-centred healthcare solutions, and create competitive advantage for our biotechnology industry.
